Prolonged Lamivudine treatment in patients with chroni active anti-Hbe positive hepatitis

被引：0
|
作者：
Fazio, V
Angarano, G
Scotto, G
机构：
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80457-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
457
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [31] The natural history of anti-HBE positive (precore mutant) chronic hepatitis B patients.
    Lee, YM
    Wai, DCT
    Lim, LL
    Dong, P
    Perumal, V
    Chung, CK
    Lim, TP
    Ho, I
    Yeoh, KG
    Ho, KY
    Lim, SG
    HEPATOLOGY, 2000, 32 (04) : 575A - 575A
  • [32] The course of anti-HBe/HBV-DNA positive chronic liver disease during long term lamivudine treatment
    Di Marco, V
    Marzano, A
    Lampertico, P
    Andreone, P
    Santantonio, T
    Almasio, P
    Rizzetto, M
    Craxi, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 25 - 25
  • [33] INTERFERON THERAPY FOR THE ANTI-HBE POSITIVE FORM OF CHRONIC HEPATITIS-B
    ALBERTI, A
    FATTOVICH, G
    ANTIVIRAL RESEARCH, 1994, 24 (2-3) : 145 - 153
  • [34] Igm anti-HBc as diagnostic criterium for chronic anti-HBe positive hepatitis B
    Colombatto, P
    Oliveri, F
    Randone, A
    Gallo, M
    Verme, G
    Flichman, D
    Bonino, F
    Brunetto, MR
    HEPATOLOGY, 1996, 23 (01) : P109 - P109
  • [35] Two years of lamivudine therapy in anti-HBe-positive patients with chronic hepatitis B
    Buti, M
    Cotrina, M
    Jardi, R
    de Castro, EC
    Rodriguez-Frias, F
    Sánchez-Avila, F
    Esteban, R
    Guardia, J
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (04) : 270 - 275
  • [36] Lamivudine/interferon combination therapy prevents the appearance of YMDD mutants in anti-HBE positive chronic hepatitis B: A controlled pilot study
    Levrero, M
    Stivali, G
    Rossini, A
    Soccorsi, F
    Paffetti, R
    Gallo, I
    Bonaventura, ME
    Bombardieri, G
    Iaiani, GC
    Balsano, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 174 - 174
  • [37] VIRAL REPLICATION AND CLINICAL EVOLUTION OF ANTI-HBE POSITIVE CHRONIC B-HEPATITIS
    SANCHEZTAPIAS, J
    MAS, A
    COSTA, J
    BALLESTA, A
    BRUGUERA, M
    RODES, J
    JOURNAL OF HEPATOLOGY, 1988, 6 (03) : P25 - P26
  • [38] Lamivudine/interferon combination therapy for 12 months prevents the appearance of YMDD mutants in anti-HBe positive chronic hepatitis B patients: A controlled pilot study
    Santantonio, T
    Niro, G
    Sinisi, E
    Insalata, M
    Facciorusso, D
    Gravinese, E
    Andriulli, A
    Pastore, G
    JOURNAL OF HEPATOLOGY, 2001, 34 : 134 - 134
  • [39] Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
    Santantonio, T
    Mazzola, M
    Iacovazzi, T
    Miglietta, A
    Guastadisegni, A
    Pastore, G
    JOURNAL OF HEPATOLOGY, 2000, 32 (02) : 300 - 306
  • [40] EFFECT OF IMMUNOSUPPRESSIVE THERAPY ON HBSAG-POSITIVE CHRONIC ACTIVE HEPATITIS IN RELATION TO PRESENCE OR ABSENCE OF HBEAG AND ANTI-HBE
    SAGNELLI, E
    PICCININO, F
    MANZILLO, G
    FELACO, FM
    FILIPPINI, P
    MAIO, G
    PASQUALE, G
    IZZO, CM
    HEPATOLOGY, 1983, 3 (05) : 690 - 695
12345